Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…ximab, and plasmapheresis, followed by maintenance therapy with mycophenolate mofetil and voclosporin, can result in significant renal and pulmonary …
… was used in 68.8% vs 52.9%, Anifrolumab in 12.5% vs 35.3%, and Rituximab in 18.8% vs 11.8% (early vs late).The most frequent clinical ma…
…tment escalation, including GC, azathioprine (150 mg/daily) and hydroxychloroquine (400 mg/daily). However, only hemoglobin levels improved, while…
…. Rituximab showed the highest response rate (86%), followed by mycophenolate mofetil (76.9%) and hydroxychloroquine (75%) ( table 1).Abstract PO:10:…
…ling is a central driver of systemic lupus erythematosus (SLE). Anifrolumab, an anti-IFNAR1 monoclonal antibody, improves outcomes in moder…
…CSF. We gave methylprednisolone, plasma exchange, rituximab and cyclophosphamide. However, despite initial improvement, he had five relapses. We…
… diastolic dysfunction, and 16 (36%) patients experienced MACE. Rituximab significantly decreased maximal T1 values (p=0.029), a marker o…
…lasma exchange, high-dose corticosteroids, cyclophosphamide and rituximab. Despite a number of poor prognostic factors, including require…
…nd with low uM affinity to the Fc receptor FcGRIIIa, similar to Rituximab.Conclusions We demonstrate the feasibility of using an Fc-fusio…
…erence Strati P, Feng L, Tyshevich A, et al. A phase I trial of evorpacept, lenalidomide, and rituximab for patients with B-cell non-hodgk…
… we have demonstrated the effectiveness of early treatment with Rituximab in these cases.…